Jefferies Group reaffirmed their hold rating on shares of Adeptus Health Inc. (NYSE:ADPT) in a report published on Monday morning. They currently have a $13.00 price objective on the stock.

ADPT has been the topic of a number of other reports. Bank of America Corp. downgraded shares of Adeptus Health from a buy rating to an underperform rating in a research note on Wednesday, November 2nd. Goldman Sachs Group Inc. set a $80.00 price target on shares of Adeptus Health and gave the stock a buy rating in a research note on Thursday, September 8th. JMP Securities reaffirmed a buy rating on shares of Adeptus Health in a research note on Thursday, September 22nd. KeyCorp set a $31.00 price target on shares of Adeptus Health and gave the stock a buy rating in a research note on Wednesday, November 2nd. Finally, Stephens downgraded shares of Adeptus Health from an overweight rating to an equal weight rating in a research note on Wednesday, November 2nd. Three equities research analysts have rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the stock. The company presently has an average rating of Hold and a consensus price target of $44.80.

Adeptus Health (NYSE:ADPT) opened at 8.38 on Monday. The company has a 50 day moving average price of $21.06 and a 200 day moving average price of $42.05. The firm has a market cap of $137.39 million, a PE ratio of 1.49 and a beta of 1.22. Adeptus Health has a 1-year low of $7.91 and a 1-year high of $73.44.

TRADEMARK VIOLATION WARNING: This report was originally posted by Financial Market News and is owned by of Financial Market News. If you are reading this report on another domain, it was illegally stolen and republished in violation of U.S. & international trademark & copyright law. The correct version of this report can be accessed at http://www.financial-market-news.com/adeptus-health-inc-adpt-earns-hold-rating-from-jefferies-group/1211905/.

A number of institutional investors have recently bought and sold shares of ADPT. The Manufacturers Life Insurance Company acquired a new position in Adeptus Health during the third quarter valued at approximately $403,000. Investment House LLC acquired a new stake in shares of Adeptus Health during the third quarter valued at about $1,243,000. Morgan Stanley increased its stake in shares of Adeptus Health by 1,767.3% in the third quarter. Morgan Stanley now owns 1,132,828 shares of the company’s stock valued at $48,769,000 after buying an additional 1,072,161 shares in the last quarter. Principal Financial Group Inc. increased its stake in shares of Adeptus Health by 16.8% in the third quarter. Principal Financial Group Inc. now owns 111,006 shares of the company’s stock valued at $4,779,000 after buying an additional 15,933 shares in the last quarter. Finally, Northern Trust Corp increased its stake in shares of Adeptus Health by 5.2% in the third quarter. Northern Trust Corp now owns 174,373 shares of the company’s stock valued at $7,506,000 after buying an additional 8,609 shares in the last quarter.

About Adeptus Health

Adeptus Health Inc is a patient-centered healthcare company. The Company is engaged in providing emergency medical care through a network of independent freestanding emergency rooms in the United States and partnerships with various healthcare systems. The Company has approximately 80 freestanding facilities and over two licensed general hospitals.

5 Day Chart for NYSE:ADPT

Receive News & Ratings for Adeptus Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adeptus Health Inc. and related companies with MarketBeat.com's FREE daily email newsletter.